Wanfu Biological 2019-nCoV test kit (colloidal gold method),it is used for the qualitative detection of 2019-nCoV (IgM / IgG) in human serum, plasma and whole blood samples in vitro. The results are available in 15 minutes. It provides rapid detection for patients with new coronary pneumonia, asymptomatic patients, close contacts, and negative nucleic acid test Convenient on-site detection methods.It is the complementary or synergistic to nucleic acid detection.
Widely used in all levels of hospitals, fever clinics, CDC, communities, clinics, county and rural medical and health institutions for pre-checks and triages, enterprises, public institutions, schools, airports, high-speed rail stations and other public transport junction, and the detection of suspected patients such as customs inspection and quarantine.
Quickly primary screen 2019-nCoV in 15 minutes
Easy operation , early detection and treatment
Flexible scenes, no need supporting detection equipment
Screening for early mild and asymptomatic patients
The significance of antibody tests：IgM is the earliest antibody in humoral immunity and a sign of recent infection.
IgM antibodies can be detected as fast as one week after virus infection, there are differences between individuals.
1)A negative test result indicates that the patient is not infected or in the early stage or recovery period of the disease infection.
2)A positive test result indicates that the patient was recently infected with 2019-nCoV.
Guangzhou Wanfu Biotechnology Co., Ltd. is committed to the development, production and sales of rapid detection (POCT) products (including reagents and instruments) in biomedical vitro diagnostic (IVD) industry, provides professional rapid diagnosis and the products and services of chronic disease management.It is the leading domestic POCT.